AORT
アーチビオン
AORT
アーチビオン
Artivion NYSE: AORT reported second-quarter 2026 revenue of $125.8 million, up 9% year over year on a constant-currency basis, as growth in stent grafts and On-X heart valves offset modest declines in
Artivion, Inc. (AORT) Q2 2026 Earnings Call Transcript